Miclodin (Clotrimazole)

Miclodin, an azole antifungal, acts on Candida species that cause vaginal infections.

• Vaginal candidiasis: eliminates the fungal infection and relieves associated symptoms.
• Recurrent vaginal candidiasis: used as prescribed to reduce the frequency of future episodes.
• Yeast infection of the vagina: helps restore normal vaginal flora by inhibiting fungal growth.

• Clotrimazole inhibits the fungal enzyme lanosterol 14α-demethylase, a key step in ergosterol synthesis. By blocking this pathway, the drug disrupts the formation of fungal cell membranes, leading to increased membrane permeability and ultimately cell death, thereby clearing the infection.

Miclodin may cause local adverse reactions when applied vaginally.

Common Side Effects

• Irritation or burning sensation at the application site.
• Mild itching or redness.
• Vaginal discharge that may be watery or whitish.
• Dryness of the vaginal mucosa.
• Mild allergic skin reaction (rash).
• Unpleasant odor.

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis) with swelling, hives, or difficulty breathing.
• Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Significant vaginal ulceration or ulcerative lesions.
• Persistent or worsening irritation.
• Hepatotoxicity (very rare with topical use).
• Systemic fungal infection if extensive mucosal damage occurs.

Before using Miclodin, consider the following safety measures.

• Pregnancy: consult a healthcare provider before use, as safety data are limited.
• Breastfeeding: discuss potential risks with a physician.
• Allergy: avoid if you have known hypersensitivity to clotrimazole or other azole antifungals.
• Concurrent vaginal products: do not use other intravaginal medications simultaneously without medical advice.
• Duration of therapy: follow the prescribed treatment length and avoid prolonged use without supervision.
• Store at room temperature: keep in the original packaging, protect from moisture and heat.

Miclodin may interact with other medicines; monitor as indicated.

Major Interactions (Avoid)

• Systemic azole antifungals (e.g., fluconazole): concurrent use can increase systemic exposure and toxicity.
• Oral hormonal contraceptives: topical azoles may reduce contraceptive effectiveness.

Moderate Interactions (Monitor Closely)

• Topical steroids: may mask local irritation or infection signs.
• Other intravaginal medications (e.g., spermicides): monitor for reduced efficacy or increased irritation.
• Antifungal resistance: avoid overuse to prevent development of resistant Candida strains.